Filing Details
- Accession Number:
- 0001127602-19-018373
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-13 17:54:22
- Reporting Period:
- 2019-05-09
- Accepted Time:
- 2019-05-13 17:54:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1675905 | Joseph David Gaffin | 852 Winter Street Waltham MA 02451 | Svp, Clo, Alkermes, Inc. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-05-09 | 7,000 | $8.55 | 53,923 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2019-05-09 | 2,253 | $26.75 | 51,670 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2019-05-09 | 3,120 | $27.00 | 48,550 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2019-05-09 | 7,000 | $0.00 | 7,000 | $8.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-05-26 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/15/19.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/15/19.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.60 to $26.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- These options are fully vested in accordance with their terms.
Billionaire Hedge Funds
